Doribax (doripenem injection), FDA-Approved for Complicated Urinary Tract and Intra-abdominal Infections
Filed in archive Bacteria and Bacterial Infections , FDA Approvals , Treatment by Gloria Gamat on October 18, 2007

Found to have a cure rate comparable to levofloxacin and meropenem and have been shown to be active against several strains of bacteria - Doribax (doripenem injection, 500 mg intravenous infusion) - has recently approved by the FDA for the treatment of complicated urinary tract infections and intra-abdominal infections.
Doribax is a product of Johnson and Johnson Pharmaceutical Research and Development, LLC.
Find more details from FDA News and J&J Press Release.
Permalink: Doribax (doripenem injection), FDA-Approved for Complicated Urinary Tract and Intra-abdominal Infections
Tags:
Doribax doripenem injection 500 mg intravenous infusion urinary tract infections intraabdominal infe
Trackback: http://www.creative-weblogging.com/cgi-bin/mt-tb.pl/97500








